Gut Hormones as Peripheral Anti-Obesity Targets: The Drug Development Landscape
Gut hormones (GLP-1, PYY, oxyntomodulin, amylin, PP, CCK) represent the most tractable peripheral targets for obesity drugs, with GLP-1 agonists and PYY analogs leading the clinical pipeline.
Quick Facts
What This Study Found
Peripheral gut hormone-based obesity drug development focuses on GLP-1 agonists (most advanced), PYY analogs, oxyntomodulin, amylin analogs, and PP as practical anti-obesity drug targets with established physiological rationale and clinical precedent.
Key Numbers
How They Did This
review study on glp-1, neuropeptides.
Why This Research Matters
Relevant for glp-1, neuropeptides, weight-loss, clinical-trials.
The Bigger Picture
Advances peptide therapeutics research.
What This Study Doesn't Tell Us
See abstract.
Questions This Raises
- ?Further research needed.
- ?Clinical translation to evaluate.
Trust & Context
- Key Stat:
- Key finding Peripheral gut hormone-based obesity drug development focuses on GLP-1 agonists (most advanced), PYY analogs, oxyntomodulin, amylin analogs, and PP as
- Evidence Grade:
- moderate evidence.
- Study Age:
- Published in 2004.
- Original Title:
- Gut hormones as peripheral anti obesity targets.
- Published In:
- Current drug targets. CNS and neurological disorders, 3(5), 379-88 (2004)
- Authors:
- Small, Caroline J(4), Bloom, Stephen R(14)
- Database ID:
- RPEP-00978
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What was studied?
Gut Hormones as Peripheral Anti-Obesity Targets: The Drug Development Landscape
What was found?
Gut hormones (GLP-1, PYY, oxyntomodulin, amylin, PP, CCK) represent the most tractable peripheral targets for obesity drugs, with GLP-1 agonists and PYY analogs leading the clinical pipeline.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00978APA
Small, Caroline J; Bloom, Stephen R. (2004). Gut hormones as peripheral anti obesity targets.. Current drug targets. CNS and neurological disorders, 3(5), 379-88.
MLA
Small, Caroline J, et al. "Gut hormones as peripheral anti obesity targets.." Current drug targets. CNS and neurological disorders, 2004.
RethinkPeptides
RethinkPeptides Research Database. "Gut hormones as peripheral anti obesity targets." RPEP-00978. Retrieved from https://rethinkpeptides.com/research/small-2004-gut-hormones-as-peripheral
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.